3,7-dimethyl-1-propargylxanthine has been researched along with Edema in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gong, ZH; Huang, B; Jia, YX; Su, RB; Wang, ML; Wang, ZT; Yi, SP; Yu, G; Zhang, FY | 1 |
Castellino, AJ; DaRe, JS; Erion, MD; Kopcho, JJ; Ramirez-Weinhouse, M; Rosengren, S; Ugarkar, BG | 1 |
Doak, GJ; Reid, AR; Sawynok, J; Zarrindast, MR | 1 |
Besson, JM; Buritova, J; Chapman, V; Honoré, P | 1 |
Poon, A; Sawynok, J | 1 |
Masamune, A; Satoh, A; Satoh, K; Shimosegawa, T; Yamagiwa, T | 1 |
6 other study(ies) available for 3,7-dimethyl-1-propargylxanthine and Edema
Article | Year |
---|---|
Antinociceptive effects of incarvillateine, a monoterpene alkaloid from Incarvillea sinensis, and possible involvement of the adenosine system.
Topics: Adenosine; Alkaloids; Analgesics; Animals; Antineoplastic Agents, Phytogenic; Bignoniaceae; Disease Models, Animal; Edema; Freund's Adjuvant; Hyperalgesia; Interleukin-1beta; Medicine, Chinese Traditional; Mice; Monoterpenes; Motor Activity; Paclitaxel; Pain Measurement; Theobromine; Theophylline; Xanthines | 2015 |
Adenosine kinase inhibitors. 3. Synthesis, SAR, and antiinflammatory activity of a series of l-lyxofuranosyl nucleosides.
Topics: Adenosine Kinase; Animals; Anti-Inflammatory Agents, Non-Steroidal; Dose-Response Relationship, Drug; Edema; Leukocyte Count; Neutrophils; Nucleosides; Phosphorylation; Purinergic P1 Receptor Antagonists; Rats; Skin; Structure-Activity Relationship; Theobromine | 2003 |
Adenosine A3 receptor activation produces nociceptive behaviour and edema by release of histamine and 5-hydroxytryptamine.
Topics: Animals; Behavior, Animal; Body Temperature; Edema; Histamine Release; Injections, Subcutaneous; Male; Pain; Plethysmography; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Serotonin; Theobromine; Theophylline | 1997 |
UP 202-56, an adenosine analogue, selectively acts via A1 receptors to significantly decrease noxiously-evoked spinal c-Fos protein expression.
Topics: Adenosine; Administration, Oral; Animals; Carrageenan; Edema; Hindlimb; Indoles; Male; Proto-Oncogene Proteins c-fos; Purines; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Spinal Cord; Theobromine; Xanthines | 1998 |
Antinociceptive and anti-inflammatory properties of an adenosine kinase inhibitor and an adenosine deaminase inhibitor.
Topics: Adenosine Deaminase; Adenosine Deaminase Inhibitors; Adenosine Kinase; Analgesics; Animals; Anti-Inflammatory Agents; Caffeine; Carrageenan; Central Nervous System Stimulants; Deoxyadenosines; Dose-Response Relationship, Drug; Drug Synergism; Edema; Enzyme Inhibitors; Hindlimb; Hyperalgesia; Injections, Spinal; Male; Nociceptors; Pain; Pentostatin; Proto-Oncogene Proteins c-fos; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Spinal Cord; Theobromine; Time Factors | 1999 |
Activation of adenosine A2a receptor pathway reduces leukocyte infiltration but enhances edema formation in rat caerulein pancreatitis.
Topics: Adenosine; Amylases; Animals; Ceruletide; Edema; Leukocytes; Male; Pancreatitis; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Theobromine | 2002 |